Home›Stocks›TIL

TIL — structural market context

Instil Bio, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Nov 4. Each line shows the earlier value, the later value and their dates.

Price

Change from the Nov 3 close to the Nov 4 close: +4.80%.

Volume

1.30× its 20-session average on Nov 4.

Includes pre- and post-market trading.

Short interest

Short interest 170K shares (settlement Oct 15) vs 159K (Sep 30).

No new file loaded in this window. Latest file: settlement Oct 15, loaded Oct 27.

Fails-to-deliver

Latest file (settlements Oct 1–Oct 14, published Nov 3): no fails listed.

Previous file (settlements Sep 15–Sep 30, published Oct 16): 2 days with fails, largest 25K shares on Sep 22.

Analyst rating actions

None recorded in this window.

TIL events and their magnitude

Latest SEC filing in the event study

8-K 2.02 · Earnings release · filed 2026-08-13 · View on sec.gov ↗

…

How the Event Study works →

TIL short interest & days to cover

SHARES SHORT
170K
% OF FLOAT
4.7%
DAYS TO COVER
6.8
CHANGE VS PRIOR
+7.2%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-10-15 (21d ago)

How short interest and days to cover are measured →

TIL fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-22 · 44d25K$7.07
2026-09-18 · 48d2$7.21
2026-09-09 · 57d1$7.82

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

How fails-to-deliver are reported →

TIL analyst ratings

FirmActionRatingPublished
William BlairinitialiseOutperform2026-09-09

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is TIL's short interest?
As of the FINRA settlement date 2026-10-15, TIL had 170K shares sold short — 4.7% of its float, with 6.8 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
What do analysts say about TIL?
The most recent action: William Blair initialise to Outperform on 2026-09-09. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell TIL?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

Other companies in the same SEC industry: Biological Products, (No Diagnostic Substances)

BIIB · Biogen Inc.CGEM · Cullinan Therapeutics, Inc. CoELOX · Eloxx Pharmaceuticals, Inc. CoREPL · Replimune Group, Inc.RGEN · Repligen CorporationRVMD · Revolution Medicines, Inc.

Industry: SIC code 2836 as recorded on SEC EDGAR.

All tickers starting with T →

TIL: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.

Sign up with Google or emailCreate a free account